SG11201600045UA - Topical compositions for treatment of excessive sweating and methods of use thereof - Google Patents

Topical compositions for treatment of excessive sweating and methods of use thereof

Info

Publication number: SG11201600045UA
Authority: SG; Singapore
Prior art keywords: treatment; methods; topical compositions; excessive sweating; sweating
Prior art date: 2013-07-30

Application number

SG11201600045UA

Inventor

Teodora X Pene-Dumitrescu

Elizabeth K Hussey

Maria Graziella Larm

Jon Lenn

Leon Loupenok

Michael R Luke

Leandro L Santos

Virginia D Schmith

Original Assignee

Glaxosmithkline Ip Dev Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-07-30

Filing date

2014-07-30

Publication date

2016-02-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51626097&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201600045U(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-07-30 Application filed by Glaxosmithkline Ip Dev Ltd filed Critical Glaxosmithkline Ip Dev Ltd

2016-02-26 Publication of SG11201600045UA publication Critical patent/SG11201600045UA/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Birds (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Emergency Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

SG11201600045UA 2013-07-30 2014-07-30 Topical compositions for treatment of excessive sweating and methods of use thereof SG11201600045UA (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US201361859947P	2013-07-30	2013-07-30
US201461952238P	2014-03-13	2014-03-13
US201462021878P	2014-07-08	2014-07-08
PCT/IB2014/063564 WO2015015446A1 (en)	2013-07-30	2014-07-30	Topical compositions for treatment of excessive sweating and methods of use thereof

Publications (1)

Publication Number	Publication Date
SG11201600045UA true SG11201600045UA (en)	2016-02-26

Family

ID=51626097

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG11201600045UA SG11201600045UA (en)	2013-07-30	2014-07-30	Topical compositions for treatment of excessive sweating and methods of use thereof

Country Status (17)

Country	Link
US (2)	US20160166487A1 (en)
EP (1)	EP3027184A1 (en)
JP (1)	JP2016525569A (en)
KR (1)	KR20160034920A (en)
CN (1)	CN105555269A (en)
AU (1)	AU2014297993A1 (en)
BR (1)	BR112016001696A2 (en)
CA (1)	CA2919979A1 (en)
CR (1)	CR20160055A (en)
EA (1)	EA201690302A1 (en)
HK (1)	HK1225317A1 (en)
IL (1)	IL243681A0 (en)
MX (1)	MX2016001465A (en)
PE (1)	PE20160198A1 (en)
PH (1)	PH12016500096A1 (en)
SG (1)	SG11201600045UA (en)
WO (1)	WO2015015446A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2952760A1 (en)	2014-06-18	2015-12-23	Cipla Limited	Pharmaceutical composition comprising a beta-2-agonist and anticholinergic agent
CN119033770A (en)	2015-07-21	2024-11-29	博多尔实验仪器公司	Preparation of soft anticholinergic analogues
TWI767507B (en)	2016-07-21	2022-06-11	美商波德實驗股份有限公司	Formulation for soft anticholinergic analogs
EP3694491A1 (en)	2017-10-10	2020-08-19	Capsugel Belgium NV	Gelling multiparticulates
WO2021092090A1 (en) *	2019-11-05	2021-05-14	Dermira, Inc.	Methods for palmar or plantar administration of pharmaceutical compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4824676A (en) *	1984-10-11	1989-04-25	Schering Corporation	Physiological means of enhancing transdermal delivery of drugs
US4885282A (en)	1987-07-02	1989-12-05	Thornfeldt Carl R	Treatment of hyperhidrosis, ichthyosis and wrinkling
US5512555A (en)	1994-07-21	1996-04-30	Merck & Co., Inc.	Method of treating sweat-related conditions using finasteride, epristeride and a cholestan-3-one
US6433003B1 (en)	1999-04-23	2002-08-13	Arthur M. Bobrove	Method for treating hyperhidrosis in mammals
US8980290B2 (en) *	2000-08-03	2015-03-17	Antares Pharma Ipl Ag	Transdermal compositions for anticholinergic agents
WO2004084905A2 (en)	2003-03-24	2004-10-07	University Of Florida	Use of 5-ht2c receptor activity affecting compounds for treating idiopathic hyperhidrosis and associated conditions
ES2691498T3 (en)	2004-03-03	2018-11-27	Revance Therapeutics, Inc.	Topical application and transdermal release of botulinum toxins
MY144753A (en)	2004-04-27	2011-10-31	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists
AU2008314628B2 (en) *	2007-10-18	2014-03-06	Rose U	Topical glycopyrrolate formulations
GB201113662D0 (en) *	2011-08-08	2011-09-21	Prosonix Ltd	Pharmaceutical compositions
BR112015014372A8 (en) *	2012-12-19	2019-10-29	Novartis Ag	autotaxin inhibitors, their uses, and pharmaceutical composition and combination ".

2014
- 2014-07-30 CN CN201480043419.3A patent/CN105555269A/en active Pending
- 2014-07-30 EP EP14776725.5A patent/EP3027184A1/en not_active Withdrawn
- 2014-07-30 HK HK16113787.2A patent/HK1225317A1/en unknown
- 2014-07-30 BR BR112016001696A patent/BR112016001696A2/en not_active Application Discontinuation
- 2014-07-30 CA CA2919979A patent/CA2919979A1/en not_active Abandoned
- 2014-07-30 US US14/907,956 patent/US20160166487A1/en not_active Abandoned
- 2014-07-30 EA EA201690302A patent/EA201690302A1/en unknown
- 2014-07-30 PE PE2016000111A patent/PE20160198A1/en not_active Application Discontinuation
- 2014-07-30 MX MX2016001465A patent/MX2016001465A/en unknown
- 2014-07-30 WO PCT/IB2014/063564 patent/WO2015015446A1/en not_active Ceased
- 2014-07-30 SG SG11201600045UA patent/SG11201600045UA/en unknown
- 2014-07-30 JP JP2016530655A patent/JP2016525569A/en active Pending
- 2014-07-30 US US14/446,820 patent/US20150037269A1/en not_active Abandoned
- 2014-07-30 AU AU2014297993A patent/AU2014297993A1/en not_active Abandoned
- 2014-07-30 KR KR1020167002339A patent/KR20160034920A/en not_active Withdrawn
2016
- 2016-01-14 PH PH12016500096A patent/PH12016500096A1/en unknown
- 2016-01-19 IL IL243681A patent/IL243681A0/en unknown
- 2016-01-29 CR CR20160055A patent/CR20160055A/en unknown

Also Published As

Publication number	Publication date
AU2014297993A1 (en)	2016-02-04
US20160166487A1 (en)	2016-06-16
KR20160034920A (en)	2016-03-30
HK1225317A1 (en)	2017-09-08
WO2015015446A1 (en)	2015-02-05
EA201690302A1 (en)	2016-06-30
EP3027184A1 (en)	2016-06-08
BR112016001696A2 (en)	2017-08-01
US20150037269A1 (en)	2015-02-05
PE20160198A1 (en)	2016-04-21
CA2919979A1 (en)	2015-02-05
IL243681A0 (en)	2016-04-21
CN105555269A (en)	2016-05-04
PH12016500096A1 (en)	2016-04-18
CR20160055A (en)	2016-04-04
JP2016525569A (en)	2016-08-25
MX2016001465A (en)	2016-06-02

Publication	Publication Date	Title
IL273090B (en)	2022-06-01	Methods and compositions for the treatment of cancer
IL241191A0 (en)	2015-11-30	Topical compositions and methods of treatment of topical disorders
SMT201900437T1 (en)	2019-09-09	Antifungal topical composition and methods of treatment
SG11201507867RA (en)	2015-10-29	Antimicrobial compositions and methods of use
EP2958936A4 (en)	2016-11-09	Methods and compositions for treatment of forbes-cori disease
IL244089A0 (en)	2016-04-21	Diagnostic methods and compositions for treatment of glioblastoma
IL239921A0 (en)	2015-08-31	Compositions and methods for treating severe pain
SG11201501381PA (en)	2015-04-29	Topical compositions and methods of use
SG11201506869YA (en)	2015-09-29	Antimicrobial compositions and related methods of use
SG10201710538XA (en)	2018-01-30	Compositions and methods for treating skin
EP3062767A4 (en)	2018-01-03	Skin care compositions and methods of use thereof
PL3082845T3 (en)	2021-08-02	Methods and compositions for treatment of peripheral neuropathies
PL2968478T3 (en)	2019-01-31	Compositions and methods for the treatment of carboxyhemoglobinemia
IL243681A0 (en)	2016-04-21	Topical compositions for treatment of excessive sweating and methods of use thereof
IL245015A0 (en)	2016-05-31	Icotinib-containing topical skin pharmaceutical composition and use thereof
PL3079684T3 (en)	2020-06-01	Compositions and methods for the treatment of diseases related to the renin-angiotensin-system
SI2992094T1 (en)	2018-12-31	Compositions and methods for treatment of type 1 diabetes
GB201310349D0 (en)	2013-07-24	Composition and method of use thereof
GB201301928D0 (en)	2013-03-20	Composition and method of use thereof
ZA201408732B (en)	2016-03-30	Composition and methods for treating wounds
AU2013901754A0 (en)	2013-05-30	Fabric care composition and method of use thereof